Drug safety debates focus on proposed changes to FDA

06/5/2007 | Forbes

The drug safety debate has attracted doctors, lawyers and legislators to comment on FDA operations and proposed legislation to reform the agency. The drug industry supports the Kennedy-Enzi bill requiring more transparency for clinical trials and giving FDA added authority to change drug labels and require post-market studies. Others are calling for a separate center to monitor drugs on the market or a reformed budget to lessen industry ties.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID